The DOI matches its Crossref record; 22 of the 22 references it cites were found in a registry or an index.
Evidence for a gamma-interferon receptor that regulates macrophage tumoricidal activity.
Open accessAbstract
Gamma-interferon (IFN-gamma) is the macrophage-activating factor (MAF) produced by normal murine splenic cells and the murine T cell hybridoma 24/G1 that induces nonspecific tumoricidal activity in macrophages. Incubation of 24/G1 supernatants diluted to 8.3 IRU IFN-gamma/ml with 6 X 10(6) elicited peritoneal macrophages or bone marrow-derived macrophages for 4 h at 37 degrees C, resulted in removal of 80% of the MAF activity from the lymphokine preparation. Loss of activity appeared to result from absorption and not consumption because (a) 40% of the activity was removed after exposure to macrophage for 30 min at 4 degrees C, (b) no reduction of MAF activity was detected when the 24/G1 supernatant was incubated with macrophage culture supernatants, and (c) macrophage-treated supernatants showed a selective loss of MAF activity but not interleukin 2 (IL-2) activity. Absorption was dependent on the input of either IFN-gamma or macrophages and was time dependent at 37 degrees C but not at 4 degrees C. With four rodent species tested, absorption of murine IFN-gamma displayed species specificity. However, cultured human peripheral blood monocytes and the human histiocytic lymphoma cell line U937 were able to absorb the murine lymphokine. Although the majority of murine cell lines tested absorbed 24/G1 MAF activity, two murine macrophage cell lines, P388D1 and J774, were identified which absorbed significantly reduced amounts of natural IFN-gamma. Purified murine recombinant IFN-gamma was absorbed by elicited macrophages but not by P388D1. Normal macrophages but not P388D1 bound fluoresceinated microspheres coated with recombinant IFN-gamma and binding was inhibited by pretreatment of the normal cells with 24/G1 supernatants. Scatchard plot analysis showed that 12,000 molecules of soluble 125I-recombinant IFN-gamma bound per bone marrow macrophage with a Ka of 0.9 X 10(8) M-1. Binding was quantitatively inhibitable by natural IFN-gamma but not by murine IFN alpha. IFN-beta competed only weakly. Monoclonal antibodies against IFN-gamma either inhibited or enhanced MAF activity by blocking or increasing IFN-gamma binding to macrophages, respectively. These results indicate that IFN-gamma reacts with a receptor on macrophage in a specific and saturable manner and this interaction initiates macrophage activation.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Bolton, A. E., & Hunter, W. M. (1973) · Biochemical Journal · doi:10.1042/bj1330529 · Cited by 3,254
Nathan, C. F., Murray, H. W., Wiebe, M. E., & Rubin, B. Y. (1983) · The Journal of experimental medicine · doi:10.1084/jem.158.3.670 · Cited by 1,962
The Activation of Mononuclear Phagocytes: Fact, Fancy, and Future
Cohn, Z. A. (1978) · The Journal of Immunology · doi:10.4049/jimmunol.121.3.813 · Cited by 601
Recombinant interferon-gamma increases HLA-DR synthesis and expression.
Basham, T. Y., & Merigan, T. C. (1983) · The Journal of Immunology · doi:10.4049/jimmunol.130.4.1492 · Cited by 575
SIMPLIFIED MYELOPEROXIDASE STAIN USING BENZIDINE DIHYDROCHLORIDE.
Kaplow, L. S. (1965) · PubMed · Cited by 530
Steeg, P. S., Moore, R. N., Johnson, H. M., & Oppenheim, J. J. (1982) · The Journal of experimental medicine · doi:10.1084/jem.156.6.1780 · Cited by 475
Cloning and expression of murine immune interferon cDNA.
Gray, P. W., & Goeddel, D. V. (1983) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.80.19.5842 · Cited by 446
Self-citationPace, J. L., Russell, S. W., Torres, B. A., Johnson, H. M., & Gray, P. W. (1983) · The Journal of Immunology · doi:10.4049/jimmunol.130.5.2011 · Cited by 442
Self-citationBiochemical Criteria for Activated Macrophages
Karnovsky, M. L., & Lazdins, J. K. (1978) · The Journal of Immunology · doi:10.4049/jimmunol.121.3.809 · Cited by 388
The concept of the activated macrophage.
North, R. J. (1978) · PubMed · Cited by 383
Schreiber, R. D., Pace, J. L., Russell, S. W., Altman, A., & Katz, D. H. (1983) · The Journal of Immunology · doi:10.4049/jimmunol.131.2.826 · Cited by 235
Self-citationInduction of Ia and H-2 antigens on a macrophage cell line by immune interferon.
King, D. P., & Jones, P. P. (1983) · The Journal of Immunology · doi:10.4049/jimmunol.131.1.315 · Cited by 226
Functional identity between murine γ Interferon and macrophage activating factor
Schultz, R. M., & Kleinschmidt, W. J. (1983) · Nature · doi:10.1038/305239a0 · Cited by 205
Gabel, C. A., Goldberg, D. E., & Kornfeld, S. (1983) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.80.3.775 · Cited by 186
Macrophage activation: priming activity from a T-cell hybridoma is attributable to interferon-gamma.
Pace, J. L., Russell, S. W., Schreiber, R. D., Altman, A., & Katz, D. H. (1983) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.80.12.3782 · Cited by 184
Self-citationMediators of Immunity: Lymphokines and Monokines
Rocklin, R. E., Bendtzen, K., & Greineder, D. (1980) · Advances in Immunology · doi:10.1016/s0065-2776(08)60043-7 · Cited by 173
Meerpohl, H. G., Lohmann‐Matthes, M., & Fischer, H. (1976) · European Journal of Immunology · doi:10.1002/eji.1830060313 · Cited by 137
Human interferon-gamma is internalized and degraded by cultured fibroblasts.
Anderson, P., Yip, Y. K., & Vilček, J. (1983) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)32439-6 · Cited by 109
Fidler, I. J. (1975) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/55.5.1159 · Cited by 108
Evidence for the Identity of Murine Gamma Interferon and Macrophage Activating Factor
Roberts, W. K., & Vasil, A. (1982) · Journal of Interferon Research · doi:10.1089/jir.1982.2.519 · Cited by 91
Kniep, E., Domzig, W., Lohmann-Matthes, M. L., & Kickhöfen, B. (1981) · The Journal of Immunology · doi:10.4049/jimmunol.127.2.417 · Cited by 53
Identification of Gamma-Interferon as a Murine Macrophage-Activating Factor for Tumor Cytotoxicity
Schreiber, R. D. (1984) · Springer eBooks · doi:10.1007/978-1-4757-1445-6_9 · Cited by 38
Self-citation
Cited by
The M1 and M2 paradigm of macrophage activation: Time for reassessment
Martinez, F. O., & Gordon, S. (2014) · F1000Prime Reports · doi:10.12703/p6-13 · Cited by 4,689
“The enhancement was later linked with Th1 responses and IFN-g production by antigen-activated immune cells [4] and extended to cytotoxic and antitumoral properties [5,6].”
BackgroundMeraz, M. A., White, J. M., Sheehan, K. C. F., Bach, E. A., Rodig, S. J., Dighe, A. S., Kaplan, D. H., Riley, J. K., Greenlund, A. C., Campbell, D., et al. (1996) · Cell · doi:10.1016/s0092-8674(00)81288-x · Cited by 1,656
Self-citationIRAK-M Is a Negative Regulator of Toll-like Receptor Signaling
Kobayashi, K., Hernandez, L. D., Galán, J. E., Janeway, C. A., Medzhitov, R., & Flavell, R. A. (2002) · Cell · doi:10.1016/s0092-8674(02)00827-9 · Cited by 1,286
Interferon-Gamma at the Crossroads of Tumor Immune Surveillance or Evasion
Castro, F., Cardoso, A. P., Gonçalves, R. M., Serre, K., & Oliveira, M. J. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.00847 · Cited by 1,224
Franchi, L., Amer, A., Body-Malapel, M., Kanneganti, T.-D., Özören, N., Jagirdar, R., Inohara, N., Vandenabeele, P., Bertin, J., Coyle, A., et al. (2006) · Nature Immunology · doi:10.1038/ni1346 · Cited by 1,131
Metadata
- Authors
- Celada, A., Gray, P. W., Rinderknecht, E., & Schreiber, R. D.
- Venue
- The Journal of experimental medicine
- Publisher
- Rockefeller University Press
- Published
- 1984-07-01
- Volume
- 160
- Issue
- 1
- Pages
- 55-74
- ISSN
- 0022-1007 (ISSN-L)
- 1540-9538
- OpenAlex
- W2061883989
- Cited by
- 465
- References
- 22
- FWCI
- 9.71
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.